Literature DB >> 10646810

Etiology and outcome of second trimester non-immunologic fetal hydrops.

S Heinonen1, M Ryynänen, P Kirkinen.   

Abstract

BACKGROUND: This investigation was undertaken to study the conditions resulting in midtrimester fetal hydrops and to evaluate its overall prognosis as regards counseling purposes.
MATERIAL AND METHODS: The etiology of midtrimester non-immune fetal hydrops was retrospectively evaluated as regards cases detected in singleton pregnancies (n=58) from January 1987 through December 1996. The condition was diagnosed by way of routine biochemical and ultrasonographic screening of a pregnant population.
RESULTS: The rate of diagnosed midtrimester fetal hydrops was 1 in 1700 pregnancies and the overall survival rate in this usually unexpected condition was less than 10%. Various chromosomal and fetal structural abnormalities dominated as a cause of fetal hydrops, representing 44.8% and 43.1% of the cases, respectively. Infection caused only 6.9%. The underlying etiology remained unknown in only three cases. However, in 78% the diagnosis was already known prenatally. DISCUSSION: Although the overall prognosis is poor, knowledge of the primary etiology is important to determine a rational therapeutic strategy. If the results of routine investigations rule out malformation and abnormal chromosomes, follow-up serial ultrasonographic assessment may indicate that the hydropic state is transient, carrying a somewhat better prognosis.

Entities:  

Mesh:

Year:  2000        PMID: 10646810

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  8 in total

1.  The effects of asphyxia on renal function in fetal sheep at midgestation.

Authors:  A E O'Connell; A C Boyce; E R Lumbers; K J Gibson
Journal:  J Physiol       Date:  2003-08-22       Impact factor: 5.182

2.  Non-immune hydrops foetalis due to foetal tachyarrhythmia-management with transplacental amiodarone.

Authors:  Mukti Sharma; K Kapur; B K Goyal; S Narayan; Vinay Jetley
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Clinical characteristics and perinatal outcome of fetal hydrops.

Authors:  Wonkyung Yeom; E Sun Paik; Jung-Joo An; Soo-Young Oh; Suk-Joo Choi; Cheong-Rae Roh; Jong-Hwa Kim
Journal:  Obstet Gynecol Sci       Date:  2015-03-16

4.  Etiology and Perinatal Outcome of Nonimmune Hydrops Fetalis in Southern China.

Authors:  Sheng He; Linlin Wang; Pingshan Pan; Hongwei Wei; Dahua Meng; Juan Du; Xiaoxian Tian; Chenguang Zheng; Xiaoxia Qiu; Guoyang Luo
Journal:  AJP Rep       Date:  2017-06-12

5.  Etiology and Outcome of non-immune Hydrops Fetalis in Southern China: report of 1004 cases.

Authors:  Dahua Meng; Qifei Li; Xuehua Hu; Lifang Wang; Shuyin Tan; Jiasun Su; Yue Zhang; Weijia Sun; Biyan Chen; Sheng He; Fei Lin; Bobo Xie; Shaoke Chen; Pankaj B Agrawal; Shiyu Luo; Chunyun Fu
Journal:  Sci Rep       Date:  2019-07-24       Impact factor: 4.379

6.  Frequency and Prognosis of Hydrops Fetalis: A 10-Year Single-Center Experience.

Authors:  Ebru Turkoglu Unal; Ali Bulbul; Evrim Kiray Bas; Hasan Sinan Uslu
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-09-24

7.  Isolated non-immune hydrops fetalis: an observational study on complete spontaneous resolution, perinatal outcome, and long-term follow-up.

Authors:  Sophie Neveling; Alexander Johannes Knippel; Peter Kozlowski
Journal:  Arch Gynecol Obstet       Date:  2022-08-22       Impact factor: 2.493

8.  Is Fetal Hydrops in Turner Syndrome a Risk Factor for the Development of Maternal Mirror Syndrome?

Authors:  Ivonne Alexandra Bedei; Alexander Graf; Karl-Philipp Gloning; Matthias Meyer-Wittkopf; Daria Willner; Martin Krapp; Sabine Hentze; Alexander Scharf; Jan Degenhardt; Kai-Sven Heling; Peter Kozlowski; Kathrin Trautmann; Kai Jahns; Anne Geipel; Ismail Tekesin; Michael Elsässer; Lucas Wilhelm; Ingo Gottschalk; Jan-Erik Baumüller; Cahit Birdir; Felix Zöllner; Aline Wolter; Johanna Schenk; Tascha Gehrke; Corinna Keil; Jimmy Espinosa; Roland Axt-Fliedner
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.